跳至主要内容
临床试验/NCT00706875
NCT00706875已完成不适用

A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2008年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
59
试验地点
1
主要终点
The primary outcomes include reproductive concerns (as measured by the Reproductive Concern Scale, RCS) and sexual functioning (as measured by the Female Sexual Function Index, FSFI).

研究概览

简要总结

The purpose of this study is to collect information on the effects of treatment for gestational trophoblastic disease (GTD). We plan to use the findings from this study to better understand GTD survivors' health and quality of life.

We would like to know more about the health, quality of life and pregnancies of women treated for GTD. This information will be used to try and improve the treatments for women who have this disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pathology confirmed GTD by MSKCC
  • Sufficient proficiency in the English language to respond to quality of life surveys
  • Age ≥ 18 years
  • Benign or malignant disease
  • Treated with surgery and/or chemotherapy or observation

排除标准

  • 未提供

结局指标

主要结局

The primary outcomes include reproductive concerns (as measured by the Reproductive Concern Scale, RCS) and sexual functioning (as measured by the Female Sexual Function Index, FSFI).

时间窗: conclusion of the study

次要结局

  • To describe the prevalence of premature menopause and increased bone loss through the Menopausal Symptom Check List and medical follow-up information.(conclusion of the study)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验